A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

December 31, 2005

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Gabitril

Trial Locations (19)

10021

Eastside Comprehensive Medical Center, New York

10023

Medical and Behavioral Health Research, PC, New York

11235

Social Psychiatry Research Inst., Brooklyn

29407

South East Health Consultants, LLC, Charleston

30328

Atlanta Institute of Medicine & Research - Atlanta Clinic, Atlanta

32257

UF Behavioral Health Clinic, Jacksonville

33407

Janus Center for Psychiatric Research, West Palm Beach

45242

Hartford Research Group Ltd., Cincinnati

48336

Summit Research Network, Farmington Hills

53223

Northbrooke Research, Brown Deer

62025

Cunningham Clinical Research, LLC, Edwardsville

70115

LSUHSC Anxiety and Mood Disorders Clinic, New Orleans

90024

Pacific Institute for Medical Research, Inc., Los Angeles

91786

Pacific Clinical Research Medical Group, Upland

92108

Affiliated Research Institute, San Diego

92123

Health Quest Clinical Trials, San Diego

92660

Pharmacology Research Institute, Newport Beach

97301

Oregon Center for Clinical Investigations, Inc., Salem

98004

Northwest Clinical Research Center, Bellevue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00236054 - A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter